Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 11.16% | -34.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.16% | -34.83% | |||
| Cost of Revenue | 9.84% | -36.29% | |||
| Gross Profit | 11.92% | -33.95% | |||
| SG&A Expenses | 22.45% | -26.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.08% | -30.03% | |||
| Operating Income | -98.24% | -8,381.82% | |||
| Income Before Tax | -47.40% | -74.52% | |||
| Income Tax Expenses | -13.29% | 52.13% | |||
| Earnings from Continuing Operations | -43.35% | -72.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -588.57% | 159.32% | |||
| Net Income | -53.84% | -62.28% | |||
| EBIT | -98.24% | -8,381.82% | |||
| EBITDA | -127.08% | -405.60% | |||
| EPS Basic | -53.53% | -56.49% | |||
| Normalized Basic EPS | -65.11% | -51.09% | |||
| EPS Diluted | -53.53% | -56.49% | |||
| Normalized Diluted EPS | -65.11% | -51.09% | |||
| Average Basic Shares Outstanding | 0.25% | 3.74% | |||
| Average Diluted Shares Outstanding | 0.25% | 3.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||